Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes

Biomaterials

Volumn 34, Issue 23, 2013, Pages 5813-5820

  Zhang, Donghui ^a   Shadrin, Ilya Y ^a   Lam, Jason ^b   Xian, Hai Qian ^b   Snodgrass, H Ralph ^b   Bursac, Nenad ^a  

^a Duke University   (United States)

^b VistaGen Therapeutics Inc   (United States)

Author keywords

Adrenergic stimulation; Cardiac tissue engineering; Human pluripotent stem cells; Hydrogel; Optical mapping

Indexed keywords

ADRENERGIC STIMULATION; CARDIAC TISSUE ENGINEERING; CONDUCTION VELOCITY; CULTURE ENVIRONMENTS; IMPLICATIONS FOR FUTURES; NEGATIVE CORRELATION; OPTICAL MAPPING; PLURIPOTENT STEM CELLS;

GENE EXPRESSION; HYDROGELS; MONOLAYERS; STEM CELLS; THREE DIMENSIONAL COMPUTER GRAPHICS; TISSUE; TISSUE ENGINEERING;

HEART;

ISOPRENALINE; MYOSIN HEAVY CHAIN ALPHA; MYOSIN LIGHT CHAIN 2; TROPONIN T;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL MATURATION; CELL STRESS; CELL STRUCTURE; EMBRYOID BODY; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILE FORCE; HUMAN; HUMAN CELL; HUMAN TISSUE; INOTROPISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; SARCOMERE; THREE DIMENSIONAL IMAGING; TISSUE ENGINEERING;

ACTION POTENTIALS; ANIMALS; CARDIOTONIC AGENTS; CELL LINE; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION; HUMANS; MICE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; PHENOTYPE; RECEPTORS, ADRENERGIC, BETA; TIME FACTORS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84877794737     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.04.026     Document Type: Article

References (42)

1. Mummery C.L., Zhang J., Ng E.S., Elliott D.A., Elefanty A.G., Kamp T.J. Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ Res 2012, 111:344-358.
2. Lian X., Zhang J., Azarin S.M., Zhu K., Hazeltine L.B., Bao X., et al. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/beta-catenin signaling under fully defined conditions. Nat Protoc 2012, 8:162-175.
3. Minami I., Yamada K., Otsuji T.G., Yamamoto T., Shen Y., Otsuka S., et al. Asmall molecule that promotes cardiac differentiation of human pluripotent stem cells under defined, cytokine- and xeno-free conditions. Cell Rep 2012, 2:1448-1460.
4. Mummery C.L., Ward D., Passier R. Differentiation of human embryonic stem cells to cardiomyocytes by coculture with endoderm in serum-free medium. Curr Protoc Stem Cell Biol 2007, 2:1F.2.1-1F.2.14.
5. Zhang J., Klos M., Wilson G.F., Herman A.M., Lian X., Raval K.K., et al. Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method. Circ Res 2012, 111:1125-1136.
6. Lian X., Hsiao C., Wilson G., Zhu K., Hazeltine L.B., Azarin S.M., et al. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci U S A 2012, 109:E1848-E1857.
7. Kattman S.J., Witty A.D., Gagliardi M., Dubois N.C., Niapour M., Hotta A., et al. Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell. 2011, 8:228-240.
8. Elliott D.A., Braam S.R., Koutsis K., Ng E.S., Jenny R., Lagerqvist E.L., et al. NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes. Nat Methods 2011, 8:1037-1040.
9. Dubois N.C., Craft A.M., Sharma P., Elliott D.A., Stanley E.G., Elefanty A.G., et al. SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells. Nat Biotechnol 2011, 29:1011-1018.
10. Hattori F., Chen H., Yamashita H., Tohyama S., Satoh Y.S., Yuasa S., et al. Nongenetic method for purifying stem cell-derived cardiomyocytes. Nat Methods 2010, 7:61-66.
11. Tohyama S., Hattori F., Sano M., Hishiki T., Nagahata Y., Matsuura T., et al. Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell 2013, 12:127-137.
12. O'Hara T., Virag L., Varro A., Rudy Y. Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation. PLoS Comput Biol 2011, 7:e1002061.
13. Poon E., Kong C.W., Li R.A. Human pluripotent stem cell-based approaches for myocardial repair: from the electrophysiological perspective. Mol Pharmacol 2011, 8:1495-1504.
14. Binah O., Dolnikov K., Sadan O., Shilkrut M., Zeevi-Levin N., Amit M., et al. Functional and developmental properties of human embryonic stem cells-derived cardiomyocytes. JElectrocardiol 2007, 40:S192-S196.
15. Liu J., Fu J.D., Siu C.W., Li R.A. Functional sarcoplasmic reticulum for calcium handling of human embryonic stem cell-derived cardiomyocytes: insights for driven maturation. Stem Cells 2007, 25:3038-3044.
16. Itzhaki I., Rapoport S., Huber I., Mizrahi I., Zwi-Dantsis L., Arbel G., et al. Calcium handling in human induced pluripotent stem cell derived cardiomyocytes. PLoS One 2011, 6:e18037.
17. Itzhaki I., Schiller J., Beyar R., Satin J., Gepstein L. Calcium handling in embryonic stem cell-derived cardiac myocytes: of mice and men. Ann N Y Acad Sci 2006, 1080:207-215.
18. Pillekamp F., Haustein M., Khalil M., Emmelheinz M., Nazzal R., Adelmann R., et al. Contractile properties of early human embryonic stem cell-derived cardiomyocytes: beta-adrenergic stimulation induces positive chronotropy and lusitropy but not inotropy. Stem Cells Dev 2012, 21:2111-2121.
19. Schaaf S., Shibamiya A., Mewe M., Eder A., Stohr A., Hirt M.N., et al. Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology. PloS One 2011, 6:e26397.
20. Lee P., Klos M., Bollensdorff C., Hou L., Ewart P., Kamp T.J., et al. Simultaneous voltage and calcium mapping of genetically purified human induced pluripotent stem cell-derived cardiac myocyte monolayers. Circ Res 2012, 110:1556-1563.
21. Kensah G., Roa Lara A., Dahlmann J., Zweigerdt R., Schwanke K., Hegermann J., et al. Murine and human pluripotent stem cell-derived cardiac bodies form contractile myocardial tissue invitro. Eur Heart J 2012, [Epub ahead of print]. 10.1093/eurheartj/ehs349.
22. Streckfuss-Bomeke K., Wolf F., Azizian A., Stauske M., Tiburcy M., Wagner S., et al. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts. Eur Heart J 2012, [Epub ahead of print]. 10.1093/eurheartj/ehs203.
23. Tulloch N.L., Muskheli V., Razumova M.V., Korte F.S., Regnier M., Hauch K.D., et al. Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ Res 2011, 109:47-59.
24. Mulieri L.A., Hasenfuss G., Leavitt B., Allen P.D., Alpert N.R. Altered myocardial force-frequency relation in human heart failure. Circulation 1992, 85:1743-1750.
25. Valderrabano M. Influence of anisotropic conduction properties in the propagation of the cardiac action potential. Prog Biophys Mol Biol 2007, 94:144-168.
26. Liau B., Christoforou N., Leong K.W., Bursac N. Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function. Biomaterials 2011, 32:9180-9187.
27. Bian W., Liau B., Badie N., Bursac N. Mesoscopic hydrogel molding to control the 3D geometry of bioartificial muscle tissues. Nat Protoc 2009, 4:1522-1534.
28. Pedrotty D.M., Klinger R.Y., Kirkton R.D., Bursac N. Cardiac fibroblast paracrine factors alter impulse conduction and ion channel expression of neonatal rat cardiomyocytes. Cardiovasc Res 2009, 83:688-697.
29. Hinds S., Bian W., Dennis R.G., Bursac N. The role of extracellular matrix composition in structure and function of bioengineered skeletal muscle. Biomaterials 2011, 32:3575-3583.
30. Bian W., Juhas M., Pfeiler T.W., Bursac N. Local tissue geometry determines contractile force generation of engineered muscle networks. Tissue Eng Part A 2012, 18:957-967.
31. Rubin R., Strayer D.S., Rubin E. Rubin's pathology: clinicopathologic foundations of medicine 2012, Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia. 6th ed.
32. Reiser P.J., Portman M.A., Ning X.H., Schomisch Moravec C. Human cardiac myosin heavy chain isoforms in fetal and failing adult atria and ventricles. Am J Physiol Heart Circ Physiol 2001, 280:H1814-H1820.
33. Lompre A.M., Nadal-Ginard B., Mahdavi V. Expression of the cardiac ventricular alpha- and beta-myosin heavy chain genes is developmentally and hormonally regulated. JBiol Chem 1984, 259:6437-6446.
34. Caspi O., Lesman A., Basevitch Y., Gepstein A., Arbel G., Habib I.H.M., et al. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ Res 2007, 100:263-272.
35. Stevens K.R., Kreutziger K.L., Dupras S.K., Korte F.S., Regnier M., Muskheli V., et al. Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue. Proc Natl Acad Sci U S A 2009, 106:16568-16573.
36. Duan Y., Liu Z., O'Neill J., Wan L.Q., Freytes D.O., Vunjak-Novakovic G. Hybrid gel composed of native heart matrix and collagen induces cardiac differentiation of human embryonic stem cells without supplemental growth factors. JCardiovasc Transl Res 2011, 4:605-615.
37. Habib M., Shapira-Schweitzer K., Caspi O., Gepstein A., Arbel G., Aronson D., et al. Acombined cell therapy and in-situ tissue-engineering approach for myocardial repair. Biomaterials 2011, 32:7514-7523.
38. Brandenburger M., Wenzel J., Bogdan R., Richardt D., Nguemo F., Reppel M., et al. Organotypic slice culture from human adult ventricular myocardium. Cardiovasc Res 2012, 93:50-59.
39. Dolnikov K., Shilkrut M., Zeevi-Levin N., Gerecht-Nir S., Amit M., Danon A., et al. Functional properties of human embryonic stem cell-derived cardiomyocytes: intracellular Ca2+ handling and the role of sarcoplasmic reticulum in the contraction. Stem Cells 2006, 24:236-245.
40. He J.Q., Ma Y., Lee Y., Thomson J.A., Kamp T.J. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res 2003, 93:32-39.
41. Flesch M., Schwinger R.H., Schiffer F., Frank K., Sudkamp M., Kuhn-Regnier F., et al. Evidence for functional relevance of an enhanced expression of the Na(+)-Ca2+ exchanger in failing human myocardium. Circulation 1996, 94:992-1002.
42. Holubarsch C., Schneider R., Pieske B., Ruf T., Hasenfuss G., Fraedrich G., et al. Positive and negative inotropic effects of DL-sotalol and D-sotalol in failing and nonfailing human myocardium under physiological experimental conditions. Circulation 1995, 92:2904-2910.